4 results match your criteria: "General Hospital of Athens 'Evangelismos-Ophthalmiatreion Athinon-Polykliniki'[Affiliation]"
Efficacy of switching from infliximab to golimumab in patients with ulcerative colitis in deep remission.
Acta Gastroenterol Belg
October 2021
Gastroenterology Department, General Hospital of Athens 'Evangelismos-Ophthalmiatreion Athinon-Polykliniki', Athen, Greece.
Article Synopsis
- A study was conducted to evaluate the effects of switching ulcerative colitis patients from infliximab to golimumab while they were in deep remission.
- The study followed 19 patients who switched to golimumab and found that they maintained clinical remission, good quality of life, and had no complications after one year.
- In comparison, the control group (who remained on infliximab) also had high remission rates, with only one patient experiencing a flare that was managed successfully.
Reply to the letter to the Editor: 'The role of coexisting cardiovascular disease on disease severity in patients with inflammatory bowel disease'.
Eur J Gastroenterol Hepatol
February 2021
Department of Gastroenterology, University Hospital of Heraklion, Crete.
Is there any role of renin-angiotensin system inhibitors in modulating inflammatory bowel disease outcome?
Eur J Gastroenterol Hepatol
March 2021
Department of Gastroenterology, University Hospital of Heraklion, Crete.
Background: Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers have been associated with improved outcomes in inflammatory bowel disease. We aimed to investigate any possible effect of antihypertensive medications on inflammatory bowel disease course.
Methods: One hundred and fifty inflammatory bowel disease patients with hypertension were compared using a 1:1 ratio with age- and gender-matched control patients with inflammatory bowel disease.
The role of coexisting cardiovascular disease on disease severity in patients with inflammatory bowel disease.
Eur J Gastroenterol Hepatol
May 2020
Department of Gastroenterology, University Hospital of Heraklion, Crete.
Objectives: Chronic inflammation has been implicated in the pathogenesis of atherosclerosis and cardiovascular disease. Data linking the severity of inflammatory bowel disease to coexisting cardiovascular disease are scarce. The aim of the present study was to investigate whether inflammatory bowel disease patients with coexistent cardiovascular disease have more severe disease.
View Article and Find Full Text PDF